Literature DB >> 27959429

MicroRNA-194 suppresses prostate cancer migration and invasion by downregulating human nuclear distribution protein.

Qi Kong1, Xu-Shen Chen1, Tian Tian1, Xiang-You Xia1, Peilin Xu1.   

Abstract

Human NudC nuclear distribution protein (hNUDC) is differentially expressed between normal and cancer cells. Based on its marked altered expression and its roles in modulating cell division, cytokineses and migration, a detailed understanding of the mechanisms regulating hNUDC expression in cancer cells is critical. In this study, we identified miR-194 as a downstream target of hNUDC and linked its expression to reduced metastatic capacity and tumorigenicity of prostate cancer (PCa) cells. Using miRNA target prediction programs, hNUDC mRNA was found to contain a potential binding site for miR-194 within its 3'UTR. A Reporter assay confirmed that post-transcriptional regulation of hNUDC was dependent on the miR-194 binding site. Forced expression of miR-194 in PCa cell lines, PC-3 and DU-145, led to a decrease in the mRNA and protein levels of hNUDC. Overexpression of miR-194 in these cells inhibited cell migration and invasion, and induced multinucleated cells. Our data showed that hNUDC knockdown by siRNA significantly reduced the migration and invasion in the PC-3 and DU-145 cells, phenocopying the results of miR-194 overexpression. Furthermore, lentivirus-mediated stable expression of miR-194 in PCa cells reduced the ability of colony formation as detected by a soft agar assay and exhibited significantly less tumorigenic ability in vivo. Our results suggest a novel role for miR-194 in effectively controlling cell metastatic processes in PCa cells via the regulation of hNUDC expression.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27959429     DOI: 10.3892/or.2016.5305

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  7 in total

1.  miR-202 suppresses prostate cancer growth and metastasis by targeting PIK3CA.

Authors:  Shengping Zhang; Jiarong Cai; Wenjun Xie; Hui Luo; Fei Yang
Journal:  Exp Ther Med       Date:  2018-06-12       Impact factor: 2.447

2.  Urinary Exosomal MicroRNAs as Potential Non-invasive Biomarkers in Breast Cancer Detection.

Authors:  Marc Hirschfeld; Gerta Rücker; Daniela Weiß; Kai Berner; Andrea Ritter; Markus Jäger; Thalia Erbes
Journal:  Mol Diagn Ther       Date:  2020-04       Impact factor: 4.074

3.  microRNA-194 is increased in polycystic ovary syndrome granulosa cell and induce KGN cells apoptosis by direct targeting heparin-binding EGF-like growth factor.

Authors:  Yi-Xuan Wu; Yan-Shan Lin; Si-Chen Li; Xi Yao; Mingwei Cheng; Lin Zhu; Hai-Ying Liu
Journal:  Reprod Biol Endocrinol       Date:  2021-11-23       Impact factor: 5.211

4.  MicroRNA-194 regulates cell viability and apoptosis by targeting CDH2 in prostatic cancer.

Authors:  Song Gao; Zhiying Zhao; Rong Wu; Lina Wu; Xin Tian; Zhenyong Zhang
Journal:  Onco Targets Ther       Date:  2018-08-14       Impact factor: 4.147

5.  Knockdown of lncRNA ZNRD1-AS1 inhibits progression of bladder cancer by regulating miR-194 and ZEB1.

Authors:  Zhixiang Gao; Shidong Li; Xufeng Zhou; Huali Li; Shasha He
Journal:  Cancer Med       Date:  2020-08-30       Impact factor: 4.452

Review 6.  Regulation of Neuroendocrine-like Differentiation in Prostate Cancer by Non-Coding RNAs.

Authors:  Eva Slabáková; Zuzana Kahounová; Jiřina Procházková; Karel Souček
Journal:  Noncoding RNA       Date:  2021-12-02

7.  Loss of microRNA-135b Enhances Bone Metastasis in Prostate Cancer and Predicts Aggressiveness in Human Prostate Samples.

Authors:  Mireia Olivan; Marta Garcia; Leticia Suárez; Marc Guiu; Laura Gros; Olga Méndez; Marina Rigau; Jaume Reventós; Miguel F Segura; Inés de Torres; Jacques Planas; Xavier de la Cruz; Roger R Gomis; Juan Morote; Ruth Rodríguez-Barrueco; Anna Santamaria
Journal:  Cancers (Basel)       Date:  2021-12-09       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.